Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Healwell AI Inc. is a technology-enabled healthcare company focused on applying artificial intelligence and data science to preventative care, clinical decision support, and healthcare data management. The company operates at the intersection of healthcare services, health data analytics, and artificial intelligence, with an emphasis on improving early disease detection, patient outcomes, and system-level efficiency. Its core strategy combines proprietary AI tools with real-world clinical data obtained through owned and affiliated healthcare operations.
The company generates revenue through a combination of AI software solutions, data services, and clinical operations, positioning itself as both a healthcare operator and a technology developer. Healwell AI was founded in 2010 under a different corporate structure and evolved through a series of restructurings and acquisitions into its current AI-focused model, rebranding as Healwell AI Inc. in 2023 to reflect its strategic emphasis on data-driven healthcare and preventative medicine.
Business Operations
Healwell AI operates through multiple business lines spanning clinical services and technology platforms. Its principal operating segments include AI & Data Science, which develops and commercializes machine-learning tools for disease detection and clinical insights, and Healthcare Services, which provides access to longitudinal patient data through owned and affiliated medical clinics. Revenue is generated from software licensing, data analytics services, and clinical service delivery.
The company maintains a vertically integrated model by controlling both the data inputs and the AI outputs. Key assets include proprietary datasets, clinical workflows, and AI models designed for early identification of chronic and complex diseases. Healwell AI operates primarily in North America and maintains several wholly owned subsidiaries that support data acquisition, software development, and clinical service delivery. Information on certain operational synergies and financial contributions of individual units is limited; data inconclusive based on available public sources.
Strategic Position & Investments
Healwell AI’s strategic direction centers on scaling preventative care solutions through AI-enabled disease detection and population health analytics. Growth initiatives include expanding its AI platform capabilities, increasing clinical data coverage, and integrating acquired technologies across its healthcare network. The company has pursued growth through acquisitions of complementary healthcare and AI-focused businesses, strengthening both its data assets and technical capabilities.
Notable subsidiaries and investments support Healwell AI’s presence in clinical research, data aggregation, and AI deployment. The company has articulated a strategy focused on emerging applications of AI in early diagnosis and risk stratification, particularly in chronic disease management. While management disclosures emphasize long-term value creation through AI-driven healthcare transformation, the financial impact and adoption scale of certain emerging technologies remain partially disclosed; data inconclusive based on available public sources.
Geographic Footprint
Healwell AI is headquartered in Canada, with primary operations concentrated in North America. Its clinical and technology operations are predominantly based in Canada, while certain data science, software, and commercial activities extend into the United States through partnerships and market participation.
The company’s geographic footprint reflects a focus on developed healthcare markets with established digital health infrastructure. Healwell AI’s international exposure beyond North America is limited, and there is no verified evidence of material operational presence outside these regions based on publicly available disclosures.
Leadership & Governance
Healwell AI is led by a management team with experience across healthcare services, capital markets, and technology development. The leadership emphasizes a strategy centered on preventative care, responsible AI deployment, and data-driven clinical decision-making. Governance is overseen by a board of directors with backgrounds in healthcare, finance, and public company leadership.
Key executives include:
- Hamed Shahbazi – Chief Executive Officer
- Alexander Dobranowski – President
- James Lee – Chief Financial Officer
- David Crick – Chief Operating Officer
- Dr. Alireza Mahdavi – Chief Medical Officer
Management has publicly emphasized integrating clinical expertise with advanced analytics to improve healthcare outcomes, while maintaining regulatory compliance and data governance standards appropriate for healthcare AI applications.